天然产物
铅(地质)
生化工程
自然(考古学)
计算机科学
药物发现
新产品开发
风险分析(工程)
化学
工程类
生物
业务
有机化学
生物化学
古生物学
营销
作者
Barrie Wilkinson,Steven J. Moss
出处
期刊:Current Opinion in Drug Discovery & Development
日期:2005-11-01
卷期号:8 (6): 748-56
被引量:5
摘要
It is now possible to rapidly and rationally modify, at a genetic level, the machinery responsible for natural product biosynthesis. This provides the opportunity to design new structures and to optimize natural product lead compounds in a way that would be extremely difficult through synthetic chemistry means alone. The technology can also be used to overcome limitations of compound supply, which might otherwise preclude natural products from progressing into clinical trials. Described herein are some recent examples which highlight how biosynthetic engineering has been applied to drug discovery and development, and which attempt, in particular, to demonstrate how the technology functions most effectively when combined with synthetic organic and medicinal chemistry.
科研通智能强力驱动
Strongly Powered by AbleSci AI